Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus V Heppt

Showing results (91-100 of 169) with videos related to

Pageof 17
Sort By:
Anticancer Research|September 29, 2023
Threshold Optimization for Tumor Markers S100b and MIA in Uveal Melanoma - A Single Center AnalysisNaemi Glaser, Anne Petzold, Anja Wessely, et al.
Journal of Cosmetic Dermatology|February 29, 2020
Dermal fillers do not induce upregulation of NLRP3 inflammasomes or expression of inflammatory cytokines in granulomasMarkus Reinholz, Benjamin M Clanner-Engelshofen, Markus V Heppt, et al.
Current Oncology (Toronto, Ont.)|February 22, 2021
A Critical Appraisal of Evidence- and Consensus-Based Guidelines for Actinic KeratosisAnja Wessely, Theresa Steeb, Franz Heppt, et al.
The Journal of Pathology. Clinical Research|March 17, 2026
Weakly supervised deep learning for cutaneous squamous and basal cell carcinoma in whole-slide histopathologyAnne Petzold, Anja Wessely, Stefan Schliep, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|December 30, 2022
One Website to Gather them All: Usability Testing of the New German SKin Cancer INFOrmation (SKINFO) Website-A Mixed-methods ApproachTheresa Steeb, Julia Brütting, Lydia Reinhardt, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 22, 2025
Real-world management of adjuvant systemic melanoma therapy: Multi-center survey of 51 DeCOG skin cancer centersMarkus Reitmajer, Elisabeth Livingstone, Lucie Heinzerling, et al.
The Oncologist|May 9, 2026
Selective internal radiotherapy and chemosaturation show equivalent survival in metastatic uveal melanoma: a retrospective multicenter studyElias A T Koch, Louisa A Schielein, Markus Reitmajer, et al.
BMC Cancer|August 12, 2017
Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine careMarkus V Heppt, Timo Siepmann, Jutta Engel, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 3, 2025
Real-world management of patients with complete response under immune-checkpoint inhibition for advanced melanomaMarkus Reitmajer, Elisabeth Livingstone, Kai-Martin Thoms, et al.
International Journal of Molecular Sciences|October 29, 2025
Checkpoint Blockade Efficacy in Uveal Melanoma Is Linked to Tumor Immunity, CD28, and CCL8Elias A T Koch, Renato Liguori, Alejandro Afonso Castro, et al.
Pageof 17

Showing results (91-100 of 169) with videos related to

Sort By:
Pageof 17
Anticancer Research|September 29, 2023
Threshold Optimization for Tumor Markers S100b and MIA in Uveal Melanoma - A Single Center AnalysisNaemi Glaser, Anne Petzold, Anja Wessely, et al.
Journal of Cosmetic Dermatology|February 29, 2020
Dermal fillers do not induce upregulation of NLRP3 inflammasomes or expression of inflammatory cytokines in granulomasMarkus Reinholz, Benjamin M Clanner-Engelshofen, Markus V Heppt, et al.
Current Oncology (Toronto, Ont.)|February 22, 2021
A Critical Appraisal of Evidence- and Consensus-Based Guidelines for Actinic KeratosisAnja Wessely, Theresa Steeb, Franz Heppt, et al.
The Journal of Pathology. Clinical Research|March 17, 2026
Weakly supervised deep learning for cutaneous squamous and basal cell carcinoma in whole-slide histopathologyAnne Petzold, Anja Wessely, Stefan Schliep, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|December 30, 2022
One Website to Gather them All: Usability Testing of the New German SKin Cancer INFOrmation (SKINFO) Website-A Mixed-methods ApproachTheresa Steeb, Julia Brütting, Lydia Reinhardt, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|November 22, 2025
Real-world management of adjuvant systemic melanoma therapy: Multi-center survey of 51 DeCOG skin cancer centersMarkus Reitmajer, Elisabeth Livingstone, Lucie Heinzerling, et al.
The Oncologist|May 9, 2026
Selective internal radiotherapy and chemosaturation show equivalent survival in metastatic uveal melanoma: a retrospective multicenter studyElias A T Koch, Louisa A Schielein, Markus Reitmajer, et al.
BMC Cancer|August 12, 2017
Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine careMarkus V Heppt, Timo Siepmann, Jutta Engel, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|January 3, 2025
Real-world management of patients with complete response under immune-checkpoint inhibition for advanced melanomaMarkus Reitmajer, Elisabeth Livingstone, Kai-Martin Thoms, et al.
International Journal of Molecular Sciences|October 29, 2025
Checkpoint Blockade Efficacy in Uveal Melanoma Is Linked to Tumor Immunity, CD28, and CCL8Elias A T Koch, Renato Liguori, Alejandro Afonso Castro, et al.
Pageof 17